Bibliography

Found 21 results

Filters: Author is Atkinson, J Hampton [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A

Grant I, Franklin D, Deutsch R, Woods SPaul, Vaida F, Ellis RJ, Letendre S, Marcotte TD, Atkinson JH, Collier AC, et al. Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology. 2014 ;82(23):2055-62.

C

Goodkin K, Vitiello B, Lyman WD, Asthana D, Atkinson JH, Heseltine PNR, Molina R, Zheng W, Khamis I, Wilkie FL, et al. Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of D-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairment. Journal of NeuroVirology [Internet]. 2006 ;12(3):178-89. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16877299

Saloner R, Paolillo EW, Heaton RK, Grelotti DJ, Stein MB, Miller AH, J Atkinson H, Letendre SL, Ellis RJ, Grant I, et al. Chronically elevated depressive symptoms interact with acute increases in inflammation to predict worse neurocognition among people with HIV. J Neurovirol. 2021 ;27(1):160-167.

Ferrara M, Umlauf A, Sanders C, Meyer JM, McCutchan JA, Duarte NA, Atkinson JH, Grant I, Ellis RJ. The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk. Psychiatry Res. 2014 ;218(1-2):201-8.

Ellis RJ, Rosario D, Clifford DB, McArthur JC, Simpson D, Alexander T, Gelman BB, Vaida F, Collier A, Marra CM, et al. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch Neurol. 2010 ;67(5):552-8.

Everall I, Heaton RK, Marcotte TD, Ellis RJ, McCutchan JA, Atkinson JH, Grant I, Mallory ME, Masliah E. Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathology (Zurich, Switzerland) [Internet]. 1999 ;9(2):209-217. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10219738

D

Everall I, Salaria S, Atkinson JH, Young C, Corbeil J, Grant I, Masliah E. Diminished somatostatin gene expression in individuals with HIV and major depressive disorder. Neurology [Internet]. 2006 ;67:1867-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17130427

E

Cherner M, Ellis RJ, Lazzaretto D, Young C, Rivera-Mindt M, Atkinson JH, Grant I, Heaton RK, HNRC. Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings. AIDS (London, England) [Internet]. 2004 ;18 Suppl 1:S27-34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15075495

Lin K, Taylor MJ, Heaton R, Franklin D, Jernigan T, Fennema-Notestine C, McCutchan A, J Atkinson H, Ellis RJ, McArthur J, et al. Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV-infected individuals. J Clin Exp Neuropsychol. 2011 ;33(3):326-34.

H

Keltner JR, Vaida F, Ellis RJ, Moeller-Bertram T, Fitzsimmons C, Duarte NA, Robinson-Papp J, Dworkin RH, Clifford DB, McArthur JC, et al. Health-related quality of life 'well-being' in HIV distal neuropathic pain is more strongly associated with depression severity than with pain intensity. Psychosomatics. 2012 ;53(4):380-6.

Keltner JR, Connolly CG, Vaida F, Jenkinson M, Fennema-Notestine C, Archibald SL, Akkari C, Schlein A, Lee J, Wang D, et al. HIV Distal Neuropathic Pain Is Associated with Smaller Ventral Posterior Cingulate Cortex. Pain Med. 2017 ;18(3):428-440.

Vitiello B, Goodkin K, Ashtana D, Shapshak P, Atkinson JH, Heseltine PNR, Eaton E, Heaton RK, Lyman WD. HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people. AIDS (London, England) [Internet]. 2007 ;21:1415-22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17589187

Keltner JR, Fennema-Notestine C, Vaida F, Wang D, Franklin DR, Dworkin RH, Sanders C, J McCutchan A, Archibald SL, Miller DJ, et al. HIV-associated distal neuropathic pain is associated with smaller total cerebral cortical gray matter. J Neurovirol. 2014 ;20(3):209-18.

Heaton RK, Franklin DR, Ellis RJ, J McCutchan A, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011 ;17(1):3-16.

I

Morgello S, Holzer CE, Ryan EL, Young C, Naseer M, Castellon SA, Frol AB, Atkinson JH, Gelman B, Grant I, et al. Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV-infected cohort: experience of the National NeuroAIDS Tissue Consortium. International Journal of Methods in Psychiatric Research [Internet]. 2006 ;15:131-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17019897

L

Letendre S, Woods SPaul, Ellis RJ, Atkinson JH, Masliah E, van den Brande G, Durelle J, Grant I, Everall I. Lithium improves HIV-associated neurocognitive impairment. AIDS (London, England) [Internet]. 2006 ;20:1885-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16954730

N

Heaton RK, Franklin DR, Deutsch R, Letendre S, Ellis RJ, Casaletto K, Marquine MJ, Woods SP, Vaida F, J Atkinson H, et al. Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis. 2015 ;60(3):473-80.

Moore DJ, Letendre SL, Morris S, Umlauf A, Deutsch R, Smith DM, Little S, Rooney A, Franklin DR, Gouaux B, et al. Neurocognitive functioning in acute or early HIV infection. J Neurovirol. 2011 ;17(1):50-7.

Byrd DA, Fellows RP, Morgello S, Franklin D, Heaton RK, Deutsch R, J Atkinson H, Clifford DB, Collier AC, Marra CM, et al. Neurocognitive impact of substance use in HIV infection. J Acquir Immune Defic Syndr. 2011 ;58(2):154-62.

P

Malvar J, Vaida F, Sanders CFitzsimons, J Atkinson H, Bohannon W, Keltner J, Robinson-Papp J, Simpson DM, Marra CM, Clifford DB, et al. Predictors of new-onset distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapy. Pain. 2015 ;156(4):731-739.

T

Moore D, Atkinson JH, Akiskal H, Gonzalez RG, Wolfson TJ, Grant I. Temperament and risky behaviors: a pathway to HIV?. Journal of Affective Disorders [Internet]. 2005 ;85(1-2):191-200. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15780689